Breast Cancer Patients With Estrogen Receptor Mutations Benefit From Switch to Fulvestrant
December 7th 2021Certain patients with breast cancer treated with an aromatase inhibitor plus palbociclib (Ibrance) could benefit from an early switch to fulvestrant (Faslodex) plus palbociclib, study finds.
Read More
Case Study: Remote Work Increases Productivity for Medication History Technicians
December 6th 2021The case study details the methodology employed by a large academic medical center to convert its medication history technician program’s workflow from on-site with in-person patient interviews to completely remote services.
Read More
Expert: Specialty Pharmacy is Changing, “Needs to Go Where the Patients Are” in the Future
November 29th 2021Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.
Watch
How the Care Setting Can Impact Patient Outcomes in the Treatment of Burkitt Lymphoma
November 10th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses how the care setting can impact patient outcomes in the treatment of Burkitt lymphoma.
Watch
Rate of Treatment-Related Mortality, Most Common Causes in the Treatment of Burkitt Lymphoma
November 9th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.
Watch
The Role of Nrf2, Vitamin K in DNA Damage Signaling, Senescence, Inflammaging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the role of Nrf2 and vitamin K in DNA damage signaling, senescence, and inflammaging.
Watch
Assessing the Link Between Senescence, Early Vascular Aging in Patients With Chronic Kidney Disease
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the link between senescence and early vascular aging in the context of chronic kidney disease.
Watch
How to Counteract the Contributing Factors to Early Vascular Aging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what may be some of the contributing factors to early vascular aging and how might they be counteracted.
Watch
How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment
November 8th 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.
Watch
Identifying, Developing Novel, Effective Therapies for Vascular Calcification, Early Vascular Aging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the next steps to identify and develop novel and effective therapeutic targets for vascular calcification and early vascular aging.
Watch
Assessing the Efficacy of Novel Treatments for Vascular Calcification in Patients With CKD
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the therapeutic strategies or treatments for vascular calcification that have been found to be effective in patients with chronic kidney disease.
Watch
Expert Discusses Challenges of Treating Individuals at Large Cancer Centers
November 7th 2021Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, discusses the challenges of treating neuroendocrine tumors in large cancer centers.
Watch